Global Bi-Specific Antibodies Market Growth (Status and Outlook) 2023-2029

March 2023 | 64 pages | ID: G4AD38866886EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.

LPI (LP Information)' newest research report, the “Bi-Specific Antibodies Industry Forecast” looks at past sales and reviews total world Bi-Specific Antibodies sales in 2022, providing a comprehensive analysis by region and market sector of projected Bi-Specific Antibodies sales for 2023 through 2029. With Bi-Specific Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bi-Specific Antibodies industry.

This Insight Report provides a comprehensive analysis of the global Bi-Specific Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bi-Specific Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bi-Specific Antibodies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bi-Specific Antibodies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bi-Specific Antibodies.

The global Bi-Specific Antibodies market size is projected to grow from US$ 3195 million in 2022 to US$ 4072.3 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.

Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.

North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Bi-Specific Antibodies market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Fragment-Based Antibodies
• IgG-Based Antibodies

Segmentation by application

• Cancer
• Haemophilia
• Other Non-Cancer Diseases

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche (Chugai)
• Amgen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bi-Specific Antibodies Market Size 2018-2029
  2.1.2 Bi-Specific Antibodies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Bi-Specific Antibodies Segment by Type
  2.2.1 Fragment-Based Antibodies
  2.2.2 IgG-Based Antibodies
2.3 Bi-Specific Antibodies Market Size by Type
  2.3.1 Bi-Specific Antibodies Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
2.4 Bi-Specific Antibodies Segment by Application
  2.4.1 Cancer
  2.4.2 Haemophilia
  2.4.3 Other Non-Cancer Diseases
2.5 Bi-Specific Antibodies Market Size by Application
  2.5.1 Bi-Specific Antibodies Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)

3 BI-SPECIFIC ANTIBODIES MARKET SIZE BY PLAYER

3.1 Bi-Specific Antibodies Market Size Market Share by Players
  3.1.1 Global Bi-Specific Antibodies Revenue by Players (2018-2023)
  3.1.2 Global Bi-Specific Antibodies Revenue Market Share by Players (2018-2023)
3.2 Global Bi-Specific Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BI-SPECIFIC ANTIBODIES BY REGIONS

4.1 Bi-Specific Antibodies Market Size by Regions (2018-2023)
4.2 Americas Bi-Specific Antibodies Market Size Growth (2018-2023)
4.3 APAC Bi-Specific Antibodies Market Size Growth (2018-2023)
4.4 Europe Bi-Specific Antibodies Market Size Growth (2018-2023)
4.5 Middle East & Africa Bi-Specific Antibodies Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Bi-Specific Antibodies Market Size by Country (2018-2023)
5.2 Americas Bi-Specific Antibodies Market Size by Type (2018-2023)
5.3 Americas Bi-Specific Antibodies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bi-Specific Antibodies Market Size by Region (2018-2023)
6.2 APAC Bi-Specific Antibodies Market Size by Type (2018-2023)
6.3 APAC Bi-Specific Antibodies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Bi-Specific Antibodies by Country (2018-2023)
7.2 Europe Bi-Specific Antibodies Market Size by Type (2018-2023)
7.3 Europe Bi-Specific Antibodies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bi-Specific Antibodies by Region (2018-2023)
8.2 Middle East & Africa Bi-Specific Antibodies Market Size by Type (2018-2023)
8.3 Middle East & Africa Bi-Specific Antibodies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BI-SPECIFIC ANTIBODIES MARKET FORECAST

10.1 Global Bi-Specific Antibodies Forecast by Regions (2024-2029)
  10.1.1 Global Bi-Specific Antibodies Forecast by Regions (2024-2029)
  10.1.2 Americas Bi-Specific Antibodies Forecast
  10.1.3 APAC Bi-Specific Antibodies Forecast
  10.1.4 Europe Bi-Specific Antibodies Forecast
  10.1.5 Middle East & Africa Bi-Specific Antibodies Forecast
10.2 Americas Bi-Specific Antibodies Forecast by Country (2024-2029)
  10.2.1 United States Bi-Specific Antibodies Market Forecast
  10.2.2 Canada Bi-Specific Antibodies Market Forecast
  10.2.3 Mexico Bi-Specific Antibodies Market Forecast
  10.2.4 Brazil Bi-Specific Antibodies Market Forecast
10.3 APAC Bi-Specific Antibodies Forecast by Region (2024-2029)
  10.3.1 China Bi-Specific Antibodies Market Forecast
  10.3.2 Japan Bi-Specific Antibodies Market Forecast
  10.3.3 Korea Bi-Specific Antibodies Market Forecast
  10.3.4 Southeast Asia Bi-Specific Antibodies Market Forecast
  10.3.5 India Bi-Specific Antibodies Market Forecast
  10.3.6 Australia Bi-Specific Antibodies Market Forecast
10.4 Europe Bi-Specific Antibodies Forecast by Country (2024-2029)
  10.4.1 Germany Bi-Specific Antibodies Market Forecast
  10.4.2 France Bi-Specific Antibodies Market Forecast
  10.4.3 UK Bi-Specific Antibodies Market Forecast
  10.4.4 Italy Bi-Specific Antibodies Market Forecast
  10.4.5 Russia Bi-Specific Antibodies Market Forecast
10.5 Middle East & Africa Bi-Specific Antibodies Forecast by Region (2024-2029)
  10.5.1 Egypt Bi-Specific Antibodies Market Forecast
  10.5.2 South Africa Bi-Specific Antibodies Market Forecast
  10.5.3 Israel Bi-Specific Antibodies Market Forecast
  10.5.4 Turkey Bi-Specific Antibodies Market Forecast
  10.5.5 GCC Countries Bi-Specific Antibodies Market Forecast
10.6 Global Bi-Specific Antibodies Forecast by Type (2024-2029)
10.7 Global Bi-Specific Antibodies Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Roche (Chugai)
  11.1.1 Roche (Chugai) Company Information
  11.1.2 Roche (Chugai) Bi-Specific Antibodies Product Offered
  11.1.3 Roche (Chugai) Bi-Specific Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Roche (Chugai) Main Business Overview
  11.1.5 Roche (Chugai) Latest Developments
11.2 Amgen
  11.2.1 Amgen Company Information
  11.2.2 Amgen Bi-Specific Antibodies Product Offered
  11.2.3 Amgen Bi-Specific Antibodies Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Amgen Main Business Overview
  11.2.5 Amgen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bi-Specific Antibodies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Fragment-Based Antibodies
Table 3. Major Players of IgG-Based Antibodies
Table 4. Bi-Specific Antibodies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Bi-Specific Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Table 7. Bi-Specific Antibodies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Bi-Specific Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Table 10. Global Bi-Specific Antibodies Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Bi-Specific Antibodies Revenue Market Share by Player (2018-2023)
Table 12. Bi-Specific Antibodies Key Players Head office and Products Offered
Table 13. Bi-Specific Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Bi-Specific Antibodies Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Bi-Specific Antibodies Market Size Market Share by Regions (2018-2023)
Table 18. Global Bi-Specific Antibodies Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Bi-Specific Antibodies Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Bi-Specific Antibodies Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Bi-Specific Antibodies Market Size Market Share by Country (2018-2023)
Table 22. Americas Bi-Specific Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Table 24. Americas Bi-Specific Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Table 26. APAC Bi-Specific Antibodies Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Bi-Specific Antibodies Market Size Market Share by Region (2018-2023)
Table 28. APAC Bi-Specific Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Table 30. APAC Bi-Specific Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Table 32. Europe Bi-Specific Antibodies Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Bi-Specific Antibodies Market Size Market Share by Country (2018-2023)
Table 34. Europe Bi-Specific Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Table 36. Europe Bi-Specific Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Bi-Specific Antibodies Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Bi-Specific Antibodies Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Bi-Specific Antibodies Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Bi-Specific Antibodies
Table 45. Key Market Challenges & Risks of Bi-Specific Antibodies
Table 46. Key Industry Trends of Bi-Specific Antibodies
Table 47. Global Bi-Specific Antibodies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Bi-Specific Antibodies Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Bi-Specific Antibodies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Bi-Specific Antibodies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Roche (Chugai) Details, Company Type, Bi-Specific Antibodies Area Served and Its Competitors
Table 52. Roche (Chugai) Bi-Specific Antibodies Product Offered
Table 53. Roche (Chugai) Bi-Specific Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Roche (Chugai) Main Business
Table 55. Roche (Chugai) Latest Developments
Table 56. Amgen Details, Company Type, Bi-Specific Antibodies Area Served and Its Competitors
Table 57. Amgen Bi-Specific Antibodies Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Bi-Specific Antibodies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Amgen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Bi-Specific Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bi-Specific Antibodies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Bi-Specific Antibodies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Bi-Specific Antibodies Sales Market Share by Country/Region (2022)
Figure 8. Bi-Specific Antibodies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Bi-Specific Antibodies Market Size Market Share by Type in 2022
Figure 10. Bi-Specific Antibodies in Cancer
Figure 11. Global Bi-Specific Antibodies Market: Cancer (2018-2023) & ($ Millions)
Figure 12. Bi-Specific Antibodies in Haemophilia
Figure 13. Global Bi-Specific Antibodies Market: Haemophilia (2018-2023) & ($ Millions)
Figure 14. Bi-Specific Antibodies in Other Non-Cancer Diseases
Figure 15. Global Bi-Specific Antibodies Market: Other Non-Cancer Diseases (2018-2023) & ($ Millions)
Figure 16. Global Bi-Specific Antibodies Market Size Market Share by Application in 2022
Figure 17. Global Bi-Specific Antibodies Revenue Market Share by Player in 2022
Figure 18. Global Bi-Specific Antibodies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Bi-Specific Antibodies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Bi-Specific Antibodies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Bi-Specific Antibodies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Bi-Specific Antibodies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Bi-Specific Antibodies Value Market Share by Country in 2022
Figure 24. United States Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Bi-Specific Antibodies Market Size Market Share by Region in 2022
Figure 29. APAC Bi-Specific Antibodies Market Size Market Share by Type in 2022
Figure 30. APAC Bi-Specific Antibodies Market Size Market Share by Application in 2022
Figure 31. China Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Bi-Specific Antibodies Market Size Market Share by Country in 2022
Figure 38. Europe Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Bi-Specific Antibodies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 57. United States Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 61. China Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 65. India Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 68. France Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 69. UK Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Bi-Specific Antibodies Market Size 2024-2029 ($ Millions)
Figure 78. Global Bi-Specific Antibodies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Bi-Specific Antibodies Market Size Market Share Forecast by Application (2024-2029)